{"id":"https://openalex.org/W2002127297","doi":"https://doi.org/10.1136/bjo.2007.128454","title":"Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4","display_name":"Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4","publication_year":2008,"publication_date":"2008-07-11","ids":{"openalex":"https://openalex.org/W2002127297","doi":"https://doi.org/10.1136/bjo.2007.128454","mag":"2002127297","pmid":"https://pubmed.ncbi.nlm.nih.gov/18621791"},"language":"en","primary_location":{"id":"doi:10.1136/bjo.2007.128454","doi":"https://doi.org/10.1136/bjo.2007.128454","is_oa":false,"landing_page_url":"https://doi.org/10.1136/bjo.2007.128454","pdf_url":null,"source":{"id":"https://openalex.org/S79587146","display_name":"British Journal of Ophthalmology","issn_l":"0007-1161","issn":["0007-1161","1468-2079"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Ophthalmology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007529484","display_name":"Robert D. Williams","orcid":"https://orcid.org/0000-0002-5719-4921","observed_orcids":["https://orcid.org/0000-0002-5719-4921"]},"institutions":[{"id":"https://openalex.org/I4210159352","display_name":"Taustine Eye Center","ror":"https://ror.org/05pv1tb51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210159352"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"R D Williams","raw_affiliation_strings":["Taustine Eye Center, Louisville, KY 40207, USA. iopdoc@att.net","Taustine Eye Center, 132 Council Road, Louisville, KY 40207, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taustine Eye Center, Louisville, KY 40207, USA. iopdoc@att.net","institution_ids":["https://openalex.org/I4210159352"]},{"raw_affiliation_string":"Taustine Eye Center, 132 Council Road, Louisville, KY 40207, USA","institution_ids":["https://openalex.org/I4210159352"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J S Cohen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123418","display_name":"Cincinnati Eye Institute","ror":"https://ror.org/02zhwmh74","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210123418"]},{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J S Cohen","raw_affiliation_strings":["Cincinnati Eye Institute and University of Cincinnati, Cincinnati, Ohio, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cincinnati Eye Institute and University of Cincinnati, Cincinnati, Ohio, USA","institution_ids":["https://openalex.org/I4210123418","https://openalex.org/I63135867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076639457","display_name":"Ronald L. Gross","orcid":"https://orcid.org/0000-0002-6398-5922","observed_orcids":["https://orcid.org/0000-0002-6398-5922"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R L Gross","raw_affiliation_strings":["Cullen Eye Institute, Baylor College of Medicine, Houston, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cullen Eye Institute, Baylor College of Medicine, Houston, Texas, USA","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082850566","display_name":"C-c Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C-c Liu","raw_affiliation_strings":["Allergan Inc., Irvine, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergan Inc., Irvine, California, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003591016","display_name":"Eleonora Safyan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Safyan","raw_affiliation_strings":["Allergan Inc., Irvine, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergan Inc., Irvine, California, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038236035","display_name":"Amy L. Batoosingh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A L Batoosingh","raw_affiliation_strings":["Allergan Inc., Irvine, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergan Inc., Irvine, California, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"for the Bimatoprost Study Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"for the Bimatoprost Study Group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5007529484"],"corresponding_institution_ids":["https://openalex.org/I4210159352"],"apc_list":null,"apc_paid":null,"fwci":4.6119,"has_fulltext":false,"cited_by_count":52,"citation_normalized_percentile":{"value":0.93995506,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"92","issue":"10","first_page":"1387","last_page":"1392"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glaucoma","display_name":"glaucoma","score":0.7210000157356262},{"id":"https://openalex.org/keywords/ocular-hypertension","display_name":"ocular hypertension","score":0.9990000128746033},{"id":"https://openalex.org/keywords/intraocular-pressure-reduction","display_name":"intraocular pressure reduction","score":0.8550000190734863},{"id":"https://openalex.org/keywords/long-term-efficacy","display_name":"long-term efficacy","score":0.6790000200271606},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.9309999942779541},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.8529999852180481},{"id":"https://openalex.org/keywords/timolol","display_name":"timolol","score":0.6930000185966492},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.703000009059906},{"id":"https://openalex.org/keywords/visual-field","display_name":"visual field","score":0.5960000157356262},{"id":"https://openalex.org/keywords/visual-acuity","display_name":"visual acuity","score":0.8220000267028809},{"id":"https://openalex.org/keywords/biomicroscopy","display_name":"biomicroscopy","score":0.6380000114440918},{"id":"https://openalex.org/keywords/fundus-examination","display_name":"fundus examination","score":0.9679999947547913},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.36399999260902405},{"id":"https://openalex.org/keywords/prostamide-analogues","display_name":"prostamide analogues","score":0.7570000290870667},{"id":"https://openalex.org/keywords/glaucoma-progression","display_name":"glaucoma progression","score":0.36800000071525574},{"id":"https://openalex.org/keywords/intraocular-pressure-variability","display_name":"intraocular pressure variability","score":0.3409999907016754}],"concepts":[{"id":"https://openalex.org/C2777336333","wikidata":"https://www.wikidata.org/wiki/Q2393348","display_name":"Bimatoprost","level":4,"score":0.9818006753921509},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9247095584869385},{"id":"https://openalex.org/C2778073030","wikidata":"https://www.wikidata.org/wiki/Q413994","display_name":"Timolol","level":3,"score":0.8137949705123901},{"id":"https://openalex.org/C2781092963","wikidata":"https://www.wikidata.org/wiki/Q650050","display_name":"Intraocular pressure","level":2,"score":0.7790694832801819},{"id":"https://openalex.org/C2778527774","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Glaucoma","level":2,"score":0.6878427863121033},{"id":"https://openalex.org/C2776521421","wikidata":"https://www.wikidata.org/wiki/Q9294051","display_name":"Ocular hypertension","level":3,"score":0.671625554561615},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.6300098299980164},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.5395407676696777},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.503405749797821},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.48658430576324463},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.43385592103004456},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21092134714126587}],"mesh":[{"descriptor_ui":"D000069580","descriptor_name":"Bimatoprost","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003008","descriptor_name":"Cloprostenol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003008","descriptor_name":"Cloprostenol","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003008","descriptor_name":"Cloprostenol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003229","descriptor_name":"Conjunctival Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005901","descriptor_name":"Glaucoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005901","descriptor_name":"Glaucoma","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007429","descriptor_name":"Intraocular Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009798","descriptor_name":"Ocular Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009798","descriptor_name":"Ocular Hypertension","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D013999","descriptor_name":"Timolol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1136/bjo.2007.128454","doi":"https://doi.org/10.1136/bjo.2007.128454","is_oa":false,"landing_page_url":"https://doi.org/10.1136/bjo.2007.128454","pdf_url":null,"source":{"id":"https://openalex.org/S79587146","display_name":"British Journal of Ophthalmology","issn_l":"0007-1161","issn":["0007-1161","1468-2079"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Ophthalmology","raw_type":"journal-article"},{"id":"pmid:18621791","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18621791","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of ophthalmology","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:open-archive.highwire.org:bjophthalmol:92/10/1387","doi":null,"is_oa":false,"landing_page_url":"http://bjo.bmj.com/cgi/content/short/92/10/1387","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"},{"id":"pmh:oai:open-archive.highwire.org:bjophthalmol:bjo.2007.128454v1","doi":null,"is_oa":false,"landing_page_url":"http://bjo.bmj.com/cgi/content/short/bjo.2007.128454v1","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1964100346","https://openalex.org/W1976253654","https://openalex.org/W2007902324","https://openalex.org/W2032258381","https://openalex.org/W2040322156","https://openalex.org/W2060184518","https://openalex.org/W2064230716","https://openalex.org/W2084633653","https://openalex.org/W2110897487","https://openalex.org/W2140594570","https://openalex.org/W2146054551","https://openalex.org/W2147093603","https://openalex.org/W2148890166","https://openalex.org/W2150290224","https://openalex.org/W2169539793","https://openalex.org/W2977587116","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2169539793","https://openalex.org/W2018408210","https://openalex.org/W2064230716","https://openalex.org/W2138342502","https://openalex.org/W2160247717","https://openalex.org/W3022667545","https://openalex.org/W1991178670","https://openalex.org/W2066012781","https://openalex.org/W2347151067","https://openalex.org/W2052946503"],"abstract_inverted_index":{"BACKGROUND:":[0],"Bimatoprost":[1,298],"0.03%":[2,29],"has":[3],"been":[4,106],"shown":[5],"to":[6,76,101,108,177,187,204,229,234],"consistently":[7],"reduce":[8],"mean":[9,170,218],"intraocular":[10],"pressure":[11],"(IOP)":[12],"more":[13,252],"than":[14,198,241,254,306],"timolol":[15,33,84,200,243,255,272,307],"0.5%":[16,34],"over":[17,314],"2":[18],"years.":[19],"To":[20],"further":[21],"evaluate":[22],"long-term":[23,265,315],"safety":[24,261],"and":[25,49,122,139,146,157,185,225,310],"efficacy,":[26],"once-daily":[27],"bimatoprost":[28,60,77,102,109,182,192,238,253,266,291],"was":[30,135,163,227,294,311],"compared":[31],"with":[32,124,181,191,199,237,242],"twice":[35,85,103,117,193,201,308],"daily":[36,79,86,104,111,119,126,184,202,240,300,309],"through":[37,62,71,128],"year":[38,168],"4.":[39],"METHODS:":[40],"In":[41],"this":[42],"multicentre,":[43],"double-masked,":[44],"randomised,":[45],"controlled":[46],"trial,":[47],"glaucoma":[48],"ocular":[50],"hypertension":[51],"patients":[52,256,269],"(n":[53,80,87,131],"=":[54,81,88,132],"152)":[55],"who":[56],"completed":[57],"phase":[58],"III":[59],"trials":[61],"month":[63,72,114,129,277],"36":[64,278],"were":[65,175,249],"enrolled":[66],"in":[67,270,289],"a":[68,96],"study":[69],"extension":[70],"48.":[73,147],"Patients":[74,99],"randomised":[75,100],"once":[78,110,125,183,239,299],"78)":[82],"or":[83,209,245,258],"35)":[89],"continued":[90,123],"on":[91],"the":[92,217,271,290],"same":[93],"regimen":[94],"for":[95],"fourth":[97],"year.":[98],"had":[105],"switched":[107],"dosing":[112,127],"at":[113,137,141,211,223],"24":[115],"(bimatoprost":[116],"daily/once":[118,194],"treatment":[120,273,292],"group),":[121],"48":[130],"39).":[133],"IOP":[134,162,171,219,303],"measured":[136],"08:00":[138,224],"10:00":[140,226],"months":[142],"39,":[143],"42,":[144],"45":[145],"Safety":[148],"measures":[149],"included":[150],"adverse":[151,281,287],"events,":[152],"biomicroscopy,":[153],"ophthalmoscopy,":[154],"visual":[155,158],"acuity":[156],"field.":[159],"RESULTS:":[160],"Baseline":[161],"comparable":[164],"among":[165],"groups.":[166],"During":[167],"4,":[169],"reductions":[172],"from":[173,221],"baseline":[174,222],"7.0":[176],"8.1":[178],"mm":[179,189,206,231],"Hg":[180,190,232],"6.5":[186],"7.9":[188],"daily,":[195],"significantly":[196],"greater":[197,236,305],"(3.8":[203],"5.8":[205],"Hg,":[207],"p<":[208],"=0.035)":[210],"all":[212],"measurements.":[213],"Over":[214],"4":[215],"years,":[216],"reduction":[220],"1.9":[228],"3.9":[230],"(35%":[233],"100%)":[235],"(p<":[244,257],"=0.013).":[246],"Low":[247],"IOPs":[248],"achieved":[250],"by":[251],"=0.042).":[259],"No":[260],"concerns":[262],"developed":[263],"during":[264],"treatment;":[267],"two":[268],"group":[274],"discontinued":[275],"after":[276],"because":[279],"of":[280],"events.":[282],"The":[283],"most":[284],"common":[285],"treatment-related":[286],"event":[288],"groups":[293],"conjunctival":[295],"hyperaemia.":[296],"CONCLUSION:":[297],"provided":[301],"sustained":[302],"lowering":[304],"well":[312],"tolerated":[313],"use.":[316]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}